Disubstituted azepan orexin receptor antagonists
US8623863B2 · kind B2 · utility
23Cited by
6References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2009 |
| Grant date | Jan 7, 2014 |
| Priority date | — |
| Expiry date | May 13, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to disubstituted azepan and oxazepan amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.